| Literature DB >> 22505655 |
Lisa M Miller Jenkins1, Stewart R Durell, Sharlyn J Mazur, Ettore Appella.
Abstract
The p53 tumor suppressor is a critical component of the cellular response to stress. As it can inhibit cell growth, p53 is mutated or functionally inactivated in most tumors. A multitude of protein-protein interactions with transcriptional cofactors are central to p53-dependent responses. In its activated state, p53 is extensively modified in both the N- and C-terminal regions of the protein. These modifications, especially phosphorylation of serine and threonine residues in the N-terminal transactivation domain, affect p53 stability and activity by modulating the affinity of protein-protein interactions. Here, we review recent findings from in vitro and in vivo studies on the role of p53 N-terminal phosphorylation. These modifications can either positively or negatively affect p53 and add a second layer of complex regulation to the divergent interactions of the p53 transactivation domain.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22505655 PMCID: PMC3499055 DOI: 10.1093/carcin/bgs145
Source DB: PubMed Journal: Carcinogenesis ISSN: 0143-3334 Impact factor: 4.944